77) Our findings suggest that the cell wall modifications could be enabled b |
78) izing age-associated modifications to the cell wall of Cn and Cg. |
79) The cell wall remains an attractive target for |
80) Indeed, HS and cell wall stress trigger the coordinated e |
81) Our results show that cell wall ultrastructure is severely modif |
82) ctal cancer (CRC), head and neck squamous cell carcinoma (HNSCC), and melanoma (MEL) |
83) promotes invasion and metastasis of renal cell carcinoma (RCC) by upregulating expre |
84) to ICI therapy among patients with renal cell carcinoma (RCC) has been uniquely cha |
85) for patients with locally advanced renal cell carcinoma (RCC), where no globally ac |
86) Oral squamous cell carcinoma (SCC) pain is more prevalen |
87) ctinic keratosis (AKs), superficial basal cell carcinoma and condylomata acuminata, |
88) potential biomarkers, including squamous cell carcinoma antigen (SCC-Ag), apolipopr |
89) rse and response to treatment of squamous cell carcinoma of the oral cavity, the sev |
90) eloablative (MA) allogeneic hematopoietic cell transplantation (HCT) in CR1. |
91) ia effects after allogeneic hematopoietic cell transplantation (HCT). |
92) efficacy of allogeneic hematopoietic stem cell transplantation (allo-HSCT) is limite |
93) y review the efficacy of mesenchymal stem cell transplantation for dental pulp regen |
94) Autologous cell transplantation in two clinical studi |
95) lizumab, Immunoglobulin, Mesenchymal stem cell transplantation showed effective trea |
96) rmine the safety and efficacy of the stem cell transplantation strategy for dental p |
97) p-like tissue was achieved using the stem cell transplantation strategy in animal mo |
98) The human oral SCC cell line (HSC-3) with homozygous deletion |
99) In addition, primary HSCs and the HSC cell line LX-2 were co-cultured with the w |
100) s the triple negative human breast cancer cell line MDA-MB-231. |
101) fficiently differentiated FBBC-1 neuronal cell line and fluorescently labeled BoHV-1 |
102) jection of an endogenously HER2-amplified cell line derived from inflammatory breast |
103) ing (RNA-seq) profiles from intra-patient cell line pairs derived from 3 HGSOC patie |
104) Human derived cell line studies have been used only in A |
105) simertinib affected people with non-small cell lung cancer (NSCLC) who had mutations |
106) gnificant normal tissue toxicity in small cell lung cancer (SCLC) and NSCLC xenograf |
107) ndogenous Bak were observed in both small cell lung cancer (SCLC) and non-small cell |
108) atients with a specific type of non-small cell lung cancer (also called NSCLC). |
109) participants with advanced ALK+ non-small cell lung cancer died or had tumor growth |
|